Outcome of 361 patients older than 60 with AML according to cytogenetic risk group and age
AMLSG score . | No. of patients . | CR, % . | Median OS, mo . | 3-y OS (95% CI) . |
|---|---|---|---|---|
| Younger than 70 y | ||||
| Not high risk | 161 | 62 | 17.5 | 0.26 (0.20-0.33) |
| High risk | 82 | 21 | 7.2 | 0.06 (0.02-0.13) |
| 70 y or older | ||||
| Not high risk | 72 | 39 | 6.3 | 0.06 (0.02-0.13) |
| High risk | 46 | 15 | 3.1 | 0.02 (0.00-0.10) |
AMLSG score . | No. of patients . | CR, % . | Median OS, mo . | 3-y OS (95% CI) . |
|---|---|---|---|---|
| Younger than 70 y | ||||
| Not high risk | 161 | 62 | 17.5 | 0.26 (0.20-0.33) |
| High risk | 82 | 21 | 7.2 | 0.06 (0.02-0.13) |
| 70 y or older | ||||
| Not high risk | 72 | 39 | 6.3 | 0.06 (0.02-0.13) |
| High risk | 46 | 15 | 3.1 | 0.02 (0.00-0.10) |
Cytogenetic risk stratification according to the system proposed in this study.